Update on #PAXGUSDT 📈
Following our previous recommendation, the $PAXG stock has increased by 10%, surpassing the support level of the ascending channel.
Our first profit-taking target was achieved at $5000 ✅
If the strong momentum continues, the next target for upward movement is at $5200 - $5300 🎯
#USIranStandoff
#PAXG
$PAXG ‌

What do you think about the market trend next week? Feel free to join the chatroom for discussion. Volatile shakeouts may be unavoidable, but the strategy is already in place.
Is it letting opportunities slip away quietly, or seizing the rhythm and taking decisive action—different choices lead to completely different outcomes.
#美国部分停摆结束 #加密市场隔夜V型震荡

#PartialGovernmentShutdownEnds 📈 Analysis: The "V-Shaped" Resurrection of Precious Metals
The recent volatility in Gold and Silver hasn't been a collapse—it’s been a "healthy reset." After the January 2026 peaks ($5,600 Au / $120 Ag), the market underwent a violent but necessary cleansing of leveraged positions.
🔍 Why the Flash Crash Happened
The "cleansing" wasn't accidental. It was driven by a perfect storm:
The "Warsh Effect": The nomination of Kevin Warsh as Fed Chair signaled a pivot toward a hawkish, "Strong Dollar" policy, sparking massive profit-taking.
The Margin Squeeze: Higher CME

Real-time order, afternoon small stop-loss order

#VitalikSellsETH 🤔📉
When someone like Vitalik moves ETH, markets notice — not because it always predicts direction, but because it impacts perception and positioning.
Yes, there are reports of ETH being sold from wallets associated with Vitalik — but let’s break this down with structure, not emotion:
🔹 Context Matters
Whale distribution can be strategic: tax obligations, diversification, ecosystem funding — not necessarily bearish intent.
🔹 Supply vs Demand
A single wallet sale doesn’t shift the macro narrative if inflows, adoption, and network fundamentals remain strong.
🔹 Market Psychol

#PartialGovernmentShutdownEnds 🇺🇸📊
The uncertainty that weighed heavily on markets just lifted — the partial U.S. government shutdown is officially over.
This isn’t just political news… it’s liquidity news. When fiscal deadlocks ease, investor risk appetite tends to recover quickly.
Here’s what this means for crypto & macro:
🟢 Market Sentiment Improves
Risk-off mood softens as fiscal clarity returns. BTC, ETH, and risk assets often respond positively when uncertainty dissolves.
💼 Economic Data Flows Resume
Delayed reports — jobs, GDP updates, Treasury releases — can now enter price discov

$ARC Some planned to dump it at 0.100 @10million stay away of this coin.

#OL Update: On a LTF, above the gray zone is good for going higher. Massive price surge is expected.

$SOL Can we bottom out around 40, brothers? The SOL chain's dog-beating is definitely ongoing. Stock up a bit, consider it as using it to beat the dog. Is that okay? After losing everything.

💰 Tokenized equities on #Solana hit a new all-time high of $230M. $SOL#crypto

Under this heavy and profound sky, the spring snow dances all around, gentle and tranquil, contemplative and insightful, quietly kissing my cheeks, quietly slipping into my collar. The timeless delicate face brings me a touch of spring tenderness.

Shaping the Future of AI and Crypto:
In today’s fast-paced digital world, Artificial Intelligence (AI) and Cryptocurrency are not just technologies they are revolutionizing the way we live, work, and invest. When these two powerhouses combine, the possibilities are endless. That’s exactly what #XAIHiringCryptoSpecialists represents: an initiative designed to connect cutting-edge AI talent with the booming crypto industry.
Imagine a company building blockchain solutions whether it’s securing networks, creating NFT marketplaces, or innovating in decentralized finance (DeFi) applications. Such or

Semaglutide is selling like crazy 💸 The parent company of Semaglutide, Novo Nordisk, just released their 2025 annual financial report, and it's basically a money printing machine: total sales amounting to approximately 250.8 billion RMB. Currently, the only competitor that can shake its position globally is Eli Lilly's "Tirzepatide." The battle for pharmaceutical dominance between the two giants has already heated up. Tirzepatide sold $24.8 billion in the first three quarters of last year. After the full-year data is released, it's hard to say who will be the new "King of All Drugs." Interest

Your extraordinary performance is just my daily routine. Recently, I've been in the best state ever, feeling like I've reached the peak of my trading career. Currently, I have again gained 6500 points of room! Too relaxed!

💎💎💎💎💎Tokenized equities on #Solana hit a new all-time high of $230M. 💛$SOL#crypto

$BTCIf we break from above of this hidden trend, bitcoin is going to correct to the upside. Be ready!

$silver r u good to guy here? #silver